The cellular oxidation and reduction (redox) environment is influenced by the production and removal of reactive oxygen species (ROS). In recent years, several reports support the hypothesis that cellular ROS levels could function as “second messengers” regulating numerous cellular processes, including proliferation. Periodic oscillations in the cellular redox environment, a redox cycle, regulate cell-cycle progression from quiescence (G0) to proliferation (G1, S, G2, and M) and back to quiescence. A loss in the redox control of the cell cycle could lead to aberrant proliferation, a hallmark of various human pathologies. This review discusses the literature that supports the concept of a redox cycle controlling the mammalian cell cycle, with an emphasis on how this control relates to proliferative disorders including cancer, wound healing, fibrosis, cardiovascular diseases, diabetes, and neurodegenerative diseases. We hypothesize that reestablishing the redox control of the cell cycle by manipulating the cellular redox environment could improve many aspects of the proliferative disorders. Antioxid. Redox Signal. 11, 2985–3011.
AbergelRP, PizzurroD, MeekerCA, LaskG, MatsuokaLY, MinorRR, ChuML, UittoJ. Biochemical composition of the connective tissue in keloids and analysis of collagen metabolism in keloid fibroblast cultures. J Invest Dermatol, 84:384–390. 1985.
2.
AHA. American Heart Association. http://www.americanheart.org/presenter.jhtml?identifier=4478. 2009
3.
AhujaP, SdekP, MacLellanWR. Cardiac myocyte cell cycle control in development, disease, and regeneration. Physiol Rev, 87:521–544. 2007.
4.
AlbaneseC, JohnsonJ, WatanabeG, EklundN, VuD, ArnoldA, PestellRG. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J Biol Chem, 270:23589–23597. 1995.
5.
AleemE, KaldisP. Mouse models of cell cycle regulators: new paradigms. Results Probl Cell Differ, 42:271–328. 2006.
6.
AnscherMS, KongFM, MarksLB, BentelGC, JirtleRL. Changes in plasma transforming growth factor beta during radiotherapy and the risk of symptomatic radiation-induced pneumonitis. Int J Radiat Oncol Biol Phys, 37:253–258. 1997.
7.
AtzoriC, GhettiB, PivaR, SrinivasanAN, ZoloP, DelisleMB, MirraSS, MigheliA. Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis. J Neuropathol Exp Neurol, 60:1190–1197. 2001.
8.
BaasAS, BerkBC. Differential activation of mitogen-activated protein kinases by H2O2 and O2- in vascular smooth muscle cells. Circ Res, 77:29–36. 1995.
9.
BaeYS, SungJY, KimOS, KimYJ, HurKC, KazlauskasA, RheeSG. Platelet-derived growth factor-induced H(2)O(2) production requires the activation of phosphatidylinositol 3-kinase. J Biol Chem, 275:10527–10531. 2000.
10.
BanerjeeS, SmallwoodA, NargundG, CampbellS. Placental morphogenesis in pregnancies with Down's syndrome might provide a clue to pre-eclampsia. Placenta, 23:172–174. 2002.
11.
Barcellos-HoffMH, RavaniSA. Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res, 60:1254–1260. 2000.
12.
BartkovaJ, GronB, DabelsteenE, BartekJ. Cell-cycle regulatory proteins in human wound healing. Arch Oral Biol, 48:125–132. 2003.
13.
BartoszG. Reactive oxygen species: destroyers or messengers?Biochem Pharmacol, 77:1303–1315. 2009.
14.
BashanN, KovsanJ, KachkoI, OvadiaH, RudichA. Positive and negative regulation of insulin signaling by reactive oxygen and nitrogen species. Physiol Rev, 89:27–71. 2009.
15.
BauerG. Reactive oxygen and nitrogen species: efficient, selective, and interactive signals during intercellular induction of apoptosis. Anticancer Res, 20:4115–4139. 2000.
16.
BavikC, ColemanI, DeanJP, KnudsenB, PlymateS, NelsonPS. The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. Cancer Res, 66:794–802. 2006.
17.
BeckmanJS, KoppenolWH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol, 271:C1424–C1437. 1996.
BehrendL, HendersonG, ZwackaRM. Reactive oxygen species in oncogenic transformation. Biochem Soc Trans, 31:1441–1444. 2003.
20.
BeltramiAP, UrbanekK, KajsturaJ, YanSM, FinatoN, BussaniR, Nadal-GinardB, SilvestriF, LeriA, BeltramiCA, AnversaP. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med, 344:1750–1757. 2001.
21.
BennettMR, LittlewoodTD, HancockDC, EvanGI, NewbyAC. Down-regulation of the c-myc proto-oncogene in inhibition of vascular smooth-muscle cell proliferation: a signal for growth arrest?Biochem J, 302:701–708. 1994.
22.
BennettMR, MacdonaldK, ChanSW, BoyleJJ, WeissbergPL. Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques. Circ Res, 82:704–712. 1998.
23.
BergeronA, SolerP, KambouchnerM, LoiseauP, MilleronB, ValeyreD, HanceAJ, TaziA. Cytokine profiles in idiopathic pulmonary fibrosis suggest an important role for TGF-beta and IL-10. Eur Respir J, 22:69–76. 2003.
24.
BlairAS, HajduchE, LitherlandGJ, HundalHS. Regulation of glucose transport and glycogen synthesis in L6 muscle cells during oxidative stress: evidence for cross-talk between the insulin and SAPK2/p38 mitogen-activated protein kinase signaling pathways. J Biol Chem, 274:36293–36299. 1999.
25.
Bloch-DamtiA, BashanN. Proposed mechanisms for the induction of insulin resistance by oxidative stress. Antioxid Redox Signal, 7:1553–1567. 2005.
26.
BodenG. Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes. Exp Clin Endocrinol Diabetes, 111:121–124. 2003.
27.
BokochGM, KnausUG. NADPH oxidases: not just for leukocytes anymore!Trends Biochem Sci, 28:502–508. 2003.
28.
BrandeisM, RosewellI, CarringtonM, CromptonT, JacobsMA, KirkJ, GannonJ, HuntT. Cyclin B2-null mice develop normally and are fertile whereas cyclin B1-null mice die in utero. Proc Natl Acad Sci U S A, 95:4344–4349. 1998.
29.
Braun-DullaeusRC, MannMJ, DzauVJ. Cell cycle progression: new therapeutic target for vascular proliferative disease. Circulation, 98:82–89. 1998.
BrownBG, ZhaoXQ, ChaitA, FisherLD, CheungMC, MorseJS, DowdyAA, MarinoEK, BolsonEL, AlaupovicP, FrohlichJ, AlbersJJ. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med, 345:1583–1592. 2001.
33.
BrownawellAM, KopsGJ, MacaraIG, BurgeringBM. Inhibition of nuclear import by protein kinase B (Akt) regulates the subcellular distribution and activity of the forkhead transcription factor AFX. Mol Cell Biol, 21:3534–3546. 2001.
34.
BruckR, ScheyR, AeedH, HochmanA, GeninaO, PinesM. A protective effect of pyrrolidine dithiocarbamate in a rat model of liver cirrhosis. Liver Int, 24:169–176. 2004.
35.
BrunetA, SweeneyLB, SturgillJF, ChuaKF, GreerPL, LinY, TranH, RossSE, MostoslavskyR, CohenHY, HuLS, ChengHL, JedrychowskiMP, GygiSP, SinclairDA, AltFW, GreenbergME. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science, 303:2011–2015. 2004.
36.
BuettnerGR, NgCF, WangM, RodgersVG, SchaferFQ. A new paradigm: manganese superoxide dismutase influences the production of H2O2 in cells and thereby their biological state. Free Radic Biol Med, 41:1338–1350. 2006.
37.
BurchPM, HeintzNH. Redox regulation of cell-cycle re-entry: cyclin D1 as a primary target for the mitogenic effects of reactive oxygen and nitrogen species. Antioxid Redox Signal, 7:741–751. 2005.
38.
BurdonRH. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med, 18:775–794. 1995.
39.
BurdonRH, GillV. Cellularly generated active oxygen species and HeLa cell proliferation. Free Radic Res Commun, 19:203–213. 1993.
40.
BurdonRH, GillV, Rice-EvansC. Cell proliferation and oxidative stress. Free Radic Res Commun, 7:149–159. 1989.
41.
BurdonRH, GillV, Rice-EvansC. Oxidative stress and tumour cell proliferation. Free Radic Res Commun, 11:65–76. 1990.
42.
BurtonPB, YacoubMH, BartonPJ. Cyclin-dependent kinase inhibitor expression in human heart failure: a comparison with fetal development. Eur Heart J, 20:604–611. 1999.
43.
BusuttilRA, RubioM, DolleME, CampisiJ, VijgJ. Oxygen accelerates the accumulation of mutations during the senescence and immortalization of murine cells in culture. Aging Cell, 2:287–294. 2003.
44.
CalderonM, LawrenceWT, BanesAJ. Increased proliferation in keloid fibroblasts wounded in vitro. J Surg Res, 61:343–347. 1996.
45.
CameronE, PaulingL. Ascorbic acid and the glycosaminoglycans: an orthomolecular approach to cancer and other diseases. Oncology, 27:181–192. 1973.
CampisiJ. Aging, tumor suppression and cancer: high wire-act!Mech Ageing Dev, 126:51–58. 2005.
48.
CampisiJ. Cancer, aging and cellular senescence. In Vivo, 14:183–188. 2000.
49.
CampisiJ. Replicative senescence: an old lives' tale?Cell, 84:497–500. 1996.
50.
CampisiJ. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell, 120:513–522. 2005.
51.
CampisiJ. Suppressing cancer: the importance of being senescent. Science, 309:886–887. 2005.
52.
CantinAM, HubbardRC, CrystalRG. Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. Am Rev Respir Dis, 139:370–372. 1989.
53.
CarpenterAF, CarpenterPW, MarkesberyWR. Morphometric analysis of microglia in Alzheimer's disease. J Neuropathol Exp Neurol, 52:601–608. 1993.
54.
CDC. National Center for Chronic Disease Prevention and Health Promotion. http://www.cdc.gov/diabetes/faq/basics.htm. 2008
55.
CeolottoG, PapparellaI, LenziniL, SartoriM, MazzoniM, IoriE, FrancoL, GalloA, de KreutzenbergSV, TiengoA, PessinaAC, AvogaroA, SempliciniA. Insulin generates free radicals in human fibroblasts ex vivo by a protein kinase C-dependent mechanism, which is inhibited by pravastatin. Free Radic Biol Med, 41:473–483. 2006.
ChenJH, TsengTH, HoYC, LinHH, LinWL, WangCJ. Gaseous nitrogen oxides stimulate cell cycle progression by retinoblastoma phosphorylation via activation of cyclins/Cdks [correction]Toxicol Sci, 76:83–90. 2003.
58.
ChenQ, EspeyMG, SunAY, PooputC, KirkKL, KrishnaMC, KhoshDB, DriskoJ, LevineM. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc Natl Acad Sci U S A, 105:11105–11109. 2008.
59.
ChenZ, OdstrcilEA, TuBP, McKnightSL. Restriction of DNA replication to the reductive phase of the metabolic cycle protects genome integrity. Science, 316:1916–1919. 2007.
60.
ChengM, OlivierP, DiehlJA, FeroM, RousselMF, RobertsJM, SherrCJ. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J, 18:1571–1583. 1999.
61.
ChiumientoA, LamponiS, BarbucciR, DominguezA, PerezY, VillalongaR. Immobilizing Cu,Zn-superoxide dismutase in hydrogels of carboxymethylcellulose improves its stability and wound healing properties. Biochemistry (Mosc), 71:1324–1328. 2006.
62.
ChurchSL, GrantJW, RidnourLA, OberleyLW, SwansonPE, MeltzerPS, TrentJM. Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. Proc Natl Acad Sci U S A, 90:3113–3117. 1993.
63.
CiemerychMA, SicinskiP. Cell cycle in mouse development. Oncogene, 24:2877–2898. 2005.
64.
ConourJE, GrahamWV, GaskinsHR. A combined in vitro/bioinformatic investigation of redox regulatory mechanisms governing cell cycle progression. Physiol Genomics, 18:196–205. 2004.
Cozar-CastellanoI, TakaneKK, BottinoR, BalamuruganAN, StewartAF. Induction of beta-cell proliferation and retinoblastoma protein phosphorylation in rat and human islets using adenovirus-mediated transfer of cyclin-dependent kinase-4 and cyclin D1. Diabetes, 53:149–159. 2004.
67.
CreaganET, MoertelCG, O'FallonJR, SchuttAJ, O'ConnellMJ, RubinJ, FrytakS. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer: a controlled trial. N Engl J Med, 301:687–690. 1979.
68.
CrossDA, AlessiDR, CohenP, AndjelkovichM, HemmingsBA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature, 378:785–789. 1995.
CulottaE, KoshlDEJr. NO news is good news. Science, 258:1862–1865. 1992.
71.
DattoMB, YuY, WangXF. Functional analysis of the transforming growth factor beta responsive elements in the WAF1/Cip1/p21 promoter. J Biol Chem, 270:28623–28628. 1995.
72.
De MinicisS, BrennerDA. NOX in liver fibrosis. Arch Biochem Biophys, 462:266–272. 2007.
73.
Del PratoS, LeonettiF, SimonsonDC, SheehanP, MatsudaM, DeFronzoRA. Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man. Diabetologia, 37:1025–1035. 1994.
74.
DelanianS, LefaixJL. The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway. Radiother Oncol, 73:119–131. 2004.
75.
DengC, ZhangP, HarperJW, ElledgeSJ, LederP. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell, 82:675–684. 1995.
76.
DeYuliaGJJr, CarcamoJM, Borquez-OjedaO, SheltonCC, GoldeDW. Hydrogen peroxide generated extracellularly by receptor-ligand interaction facilitates cell signaling. Proc Natl Acad Sci U S A, 102:5044–5049. 2005.
77.
Di MascioP, MurphyME, SiesH. Antioxidant defense systems: the role of carotenoids, tocopherols, and thiols. Am J Clin Nutr, 53:194S–200S. 1991.
78.
DiezJ, PanizoA, HernandezM, GalindoMF, CenarruzabeitiaE, Pardo MindanFJ. Quinapril inhibits c-Myc expression and normalizes smooth muscle cell proliferation in spontaneously hypertensive rats. Am J Hypertens, 10:1147–1152. 1997.
79.
DimmelerS, FlemingI, FisslthalerB, HermannC, BusseR, ZeiherAM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature, 399:601–605. 1999.
80.
DkhissiF, RaynalS, LawrenceDA. Altered complex formation between p21waf, p27kip and their partner G1 cyclins determines the stimulatory or inhibitory transforming growth factor-beta1 growth response of human fibroblasts. Int J Oncol, 14:905–910. 1999.
81.
Dong-Le BourhisX, BerthoisY, MillotG, DegeorgesA, SylviM, MartinPM, CalvoF. Effect of stromal and epithelial cells derived from normal and tumorous breast tissue on the proliferation of human breast cancer cell lines in co-culture. Int J Cancer, 71:42–48. 1997.
82.
DuilioC, AmbrosioG, KuppusamyP, DiPaulaA, BeckerLC, ZweierJL. Neutrophils are primary source of O2 radicals during reperfusion after prolonged myocardial ischemia. Am J Physiol Heart Circ Physiol, 280:H2649–H2657. 2001.
83.
DulicV, BeneyGE, FrebourgG, DrullingerLF, SteinGH. Uncoupling between phenotypic senescence and cell cycle arrest in aging p21-deficient fibroblasts. Mol Cell Biol, 20:6741–6754. 2000.
84.
DunphyWG, KumagaiA. The cdc25 protein contains an intrinsic phosphatase activity. Cell, 67:189–196. 1991.
85.
DzauVJ, Braun-DullaeusRC, SeddingDG. Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med, 8:1249–1256. 2002.
86.
DzauVJ, GibbonsGH, PrattRE. Molecular mechanisms of vascular renin-angiotensin system in myointimal hyperplasia. Hypertension, 18:II100–II115. 1991.
87.
EvansDA, FunkensteinHH, AlbertMS, ScherrPA, CookNR, ChownMJ, HebertLE, HennekensCH, TaylorJO. Prevalence of Alzheimer's disease in a community population of older persons: higher than previously reported. JAMA, 262:2551–2556. 1989.
88.
EvansJL, GoldfineID, MadduxBA, GrodskyGM. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?Diabetes, 52:1–8. 2003.
89.
FantlV, StampG, AndrewsA, RosewellI, DicksonC. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev, 9:2364–2372. 1995.
90.
FatokunAA, StoneTW, SmithRA. Oxidative stress in neurodegeneration and available means of protection. Front Biosci, 13:3288–3311. 2008.
91.
FatraiS, ElghaziL, BalcazarN, Cras-MeneurC, KritsI, KiyokawaH, Bernal-MizrachiE. Akt induces beta-cell proliferation by regulating cyclin D1, cyclin D2, and p21 levels and cyclin-dependent kinase-4 activity. Diabetes, 55:318–325. 2006.
92.
FearnleyJM, LeesAJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain, 114:2283–2301. 1991.
93.
FernandesAP, HolmgrenA. Glutaredoxins: glutathione-dependent redox enzymes with functions far beyond a simple thioredoxin backup system. Antioxid Redox Signal, 6:63–74. 2004.
94.
FinchCE. The biology of aging in model organisms. Alzheimer Dis Assoc Disord, 17,suppl 2:S39–S41. 2003.
FinkelT, HolbrookNJ. Oxidants, oxidative stress and the biology of ageing. Nature, 408:239–247. 2000.
97.
FisherCJ, GoswamiPC. Mitochondria-targeted antioxidant enzyme activity regulates radioresistance in human pancreatic cancer cells. Cancer Biol Ther, 7:1271–1279. 2008.
98.
FolzRJ, CrapoJD. Extracellular superoxide dismutase (SOD3): tissue-specific expression, genomic characterization, and computer-assisted sequence analysis of the human EC SOD gene. Genomics, 22:162–171. 1994.
99.
FrendoJL, TherondP, BirdT, MassinN, MullerF, GuibourdencheJ, LutonD, VidaudM, AndersonWB, Evain-BrionD. Overexpression of copper zinc superoxide dismutase impairs human trophoblast cell fusion and differentiation. Endocrinology, 142:3638–3648. 2001.
100.
FrendoJL, TherondP, GuibourdencheJ, VidaudM, Evain-BrionaD. Implication of copper zinc superoxide dismutase (SOD-1) in human placenta development. Ann N Y Acad Sci, 973:297–301. 2002.
101.
FriedmanSL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem, 275:2247–2250. 2000.
102.
FuXD, CuiYH, LinGP, WangTH. Non-genomic effects of 17beta-estradiol in activation of the ERK1/ERK2 pathway induces cell proliferation through upregulation of cyclin D1 expression in bovine artery endothelial cells. Gynecol Endocrinol, 23:131–137. 2007.
103.
GalarisD, SkiadaV, BarboutiA. Redox signaling and cancer: the role of “labile” iron. Cancer Lett, 266:21–29. 2008.
GeorgiaS, BhushanA. Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass. J Clin Invest, 114:963–968. 2004.
108.
GiusD, SpitzDR. Redox signaling in cancer biology. Antioxid Redox Signal, 8:1249–1252. 2006.
109.
Gomez-IslaT, HollisterR, WestH, MuiS, GrowdonJH, PetersenRC, ParisiJE, HymanBT. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol, 41:17–24. 1997.
110.
GorbunovaV, SeluanovA, Pereira-SmithOM. Evidence that high telomerase activity may induce a senescent-like growth arrest in human fibroblasts. J Biol Chem, 278:7692–7698. 2003.
111.
GoswamiPC, SherenJ, AlbeeLD, ParsianA, SimJE, RidnourLA, HigashikuboR, GiusD, HuntCR, SpitzDR. Cell cycle-coupled variation in topoisomerase IIalpha mRNA is regulated by the 3′-untranslated region: possible role of redox-sensitive protein binding in mRNA accumulation. J Biol Chem, 275:38384–38392. 2000.
112.
GranaX, ReddyEP. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs)Oncogene, 11:211–219. 1995.
113.
GrankvistK, MarklundSL, TaljedalIB. CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse. Biochem J, 199:393–398. 1981.
114.
GrantMB, WargovichTJ, EllisEA, CaballeroS, MansourM, PepineCJ. Localization of insulin-like growth factor I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells: a potential treatment for restenosis?Circulation, 89:1511–1517. 1994.
115.
GriendlingKK, MinieriCA, OllerenshawJD, AlexanderRW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res, 74:1141–1148. 1994.
116.
GuoK, AndresV, WalshK. Nitric oxide-induced downregulation of Cdk2 activity and cyclin A gene transcription in vascular smooth muscle cells. Circulation, 97:2066–2072. 1998.
117.
HagiwaraSI, IshiiY, KitamuraS. Aerosolized administration of N-acetylcysteine attenuates lung fibrosis induced by bleomycin in mice. Am J Respir Crit Care Med, 162:225–231. 2000.
118.
HalliwellB. Oxidative stress and cancer: have we moved forward?Biochem J, 401:1–11. 2007.
119.
HalliwellB. Oxidative stress and neurodegeneration: where are we now?J Neurochem, 97:1634–1658. 2006.
120.
HalliwellB, GutteridgeJ. Antioxidant defence enzymes: catalases. Free radicals in biology and medicine, 3rd. Oxford: Oxford University Press, 1999; 936.
121.
HalliwellB, GutteridgeJM. Biologically relevant metal ion-dependent hydroxyl radical generation: an update. FEBS Lett, 307:108–112. 1992.
122.
HansenLL, IkedaY, OlsenGS, BuschAK, MosthafL. Insulin signaling is inhibited by micromolar concentrations of H(2)O(2): evidence for a role of H(2)O(2) in tumor necrosis factor alpha-mediated insulin resistance. J Biol Chem, 274:25078–25084. 1999.
123.
HarmanD. Aging: a theory based on free radical and radiation chemistry. J Gerontol, 11:298–300. 1956.
124.
HarrisN, CostaV, MacLeanM, MollapourM, Moradas-FerreiraP, PiperPW. MnSOD overexpression extends the yeast chronological (G(0)) life span but acts independently of Sir2p histone deacetylase to shorten the replicative life span of dividing cells. Free Radic Biol Med, 34:1599–1606. 2003.
125.
HeT, WeintraubNL, GoswamiPC, ChatterjeeP, FlahertyDM, DomannFE, OberleyLW. Redox factor-1 contributes to the regulation of progression from G0/G1 to S by PDGF in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol, 285:H804–H812. 2003.
126.
HeinonenOP, AlbanesD. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers: the Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med, 330:1029–1035. 1994.
127.
HinzM, KrappmannD, EichtenA, HederA, ScheidereitC, StraussM. NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol Cell Biol, 19:2690–2698. 1999.
128.
HocheggerH, TakedaS, HuntT. Cyclin-dependent kinases and cell-cycle transitions: does one fit all?Natl Rev Mol Cell Biol, 9:910–916. 2008.
129.
HoffmanA, SpetnerLM, BurkeM. Ramifications of a redox switch within a normal cell: its absence in a cancer cell. Free Radic Biol Med, 45:265–268. 2008.
130.
HolmgrenA. Redox regulation by thioredoxin and thioredoxin reductase. Biofactors, 11:63–64. 2000.
131.
HoriM, NishidaK. Oxidative stress and left ventricular remodelling after myocardial infarction. Cardiovasc Res, 81:457–464. 2009.
132.
HouZQ, LiHL, ZhaoJJ, LiGW. [Impairment of pancreatic islet beta cell function induced by intermittent high glucose through oxidative and endoplasmic reticulum stress: experiment with rat pancreatic islet beta cells]Zhonghua Yi Xue Za Zhi, 88:2002–2004. 2008.
133.
HoustisN, RosenED, LanderES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature, 440:944–948. 2006.
134.
HutterDE, TillBG, GreeneJJ. Redox state changes in density-dependent regulation of proliferation. Exp Cell Res, 232:435–438. 1997.
135.
InoshimaI, KuwanoK, HamadaN, YoshimiM, MaeyamaT, HagimotoN, NakanishiY, HaraN. Induction of CDK inhibitor p21 gene as a new therapeutic strategy against pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol, 286:L727–L733. 2004.
136.
IshidaA, SasaguriT, KosakaC, NojimaH, OgataJ. Induction of the cyclin-dependent kinase inhibitor p21(Sdi1/Cip1/Waf1) by nitric oxide-generating vasodilator in vascular smooth muscle cells. J Biol Chem, 272:10050–10057. 1997.
137.
IyerSS, RamirezAM, RitzenthalerJD, Torres-GonzalezE, Roser-PageS, MoraAL, BrighamKL, JonesDP, RomanJ, RojasM. Oxidation of extracellular cysteine/cystine redox state in bleomycin-induced lung fibrosis. Am J Physiol Lung Cell Mol Physiol, 296:L37–L45. 2009.
138.
JacksonRM, HeltonES, VieraL, OhmanT. Survival, lung injury, and lung protein nitration in heterozygous MnSOD knockout mice in hyperoxia. Exp Lung Res, 25:631–646. 1999.
139.
JeonSM, BokSH, JangMK, LeeMK, NamKT, ParkYB, RheeSJ, ChoiMS. Antioxidative activity of naringin and lovastatin in high cholesterol-fed rabbits. Life Sci, 69:2855–2866. 2001.
140.
JeongDW, KimEH, KimTS, ChungYW, KimH, KimIY. Different distributions of selenoprotein W and thioredoxin during postnatal brain development and embryogenesis. Mol Cells, 17:156–159. 2004.
141.
JordanaM, SchulmanJ, McSharryC, IrvingLB, NewhouseMT, JordanaG, GauldieJ. Heterogeneous proliferative characteristics of human adult lung fibroblast lines and clonally derived fibroblasts from control and fibrotic tissue. Am Rev Respir Dis, 137:579–584. 1988.
142.
KajsturaJ, LeriA, FinatoN, Di LoretoC, BeltramiCA, AnversaP. Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci U S A, 95:8801–8805. 1998.
143.
KalenAL, SarsourEH, VenkataramanS, GoswamiPC. Mn-superoxide dismutase overexpression enhances G2 accumulation and radioresistance in human oral squamous carcinoma cells. Antioxid Redox Signal, 8:1273–1281. 2006.
144.
KangSK, RabbaniZN, FolzRJ, GolsonML, HuangH, YuD, SamulskiTS, DewhirstMW, AnscherMS, VujaskovicZ. Overexpression of extracellular superoxide dismutase protects mice from radiation-induced lung injury. Int J Radiat Oncol Biol Phys, 57:1056–1066. 2003.
145.
KardamiE. Stimulation and inhibition of cardiac myocyte proliferation in vitro. Mol Cell Biochem, 92:129–135. 1990.
146.
KawamuraN. Cytochemical and quantitative study of protein-bound sulfhydryl and disulfide groups in eggs of Arbacia during the first cleavage. Exp Cell Res, 20:127–138. 1960.
147.
KimKY, RhimT, ChoiI, KimSS. N-Acetylcysteine induces cell cycle arrest in hepatic stellate cells through its reducing activity. J Biol Chem, 276:40591–40598. 2001.
KinnulaVL, FattmanCL, TanRJ, OuryTD. Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy. Am J Respir Crit Care Med, 172:417–422. 2005.
150.
KiyokawaH, KinemanRD, Manova-TodorovaKO, SoaresVC, HoffmanES, OnoM, KhanamD, HaydayAC, FrohmanLA, KoffA. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1)Cell, 85:721–732. 1996.
151.
KlebanoffSJ. Myeloperoxidase: friend and foe. J Leukoc Biol, 77:598–625. 2005.
KopsGJ, MedemaRH, GlassfordJ, EssersMA, DijkersPF, CofferPJ, LamEW, BurgeringBM. Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors. Mol Cell Biol, 22:2025–2036. 2002.
155.
KrimpenfortP, QuonKC, MooiWJ, LoonstraA, BernsA. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice. Nature, 413:83–86. 2001.
156.
KrishnamurthyJ, RamseyMR, LigonKL, TorriceC, KohA, Bonner-WeirS, SharplessNE. p16INK4a induces an age-dependent decline in islet regenerative potential. Nature, 443:453–457. 2006.
157.
KrtolicaA, ParrinelloS, LockettS, DesprezPY, CampisiJ. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci U S A, 98:12072–12077. 2001.
158.
KushnerJA, CiemerychMA, SicinskaE, WartschowLM, TetaM, LongSY, SicinskiP, WhiteMF. Cyclins D2 and D1 are essential for postnatal pancreatic beta-cell growth. Mol Cell Biol, 25:3752–3762. 2005.
KyawM, YoshizumiM, TsuchiyaK, IzawaY, KanematsuY, FujitaY, AliN, IshizawaK, YamauchiA, TamakiT. Antioxidant effects of stereoisomers of N-acetylcysteine (NAC), L-NAC and D-NAC, on angiotensin II-stimulated MAP kinase activation and vascular smooth muscle cell proliferation. J Pharmacol Sci, 95:483–486. 2004.
161.
LaBaerJ, GarrettMD, StevensonLF, SlingerlandJM, SandhuC, ChouHS, FattaeyA, HarlowE. New functional activities for the p21 family of CDK inhibitors. Genes Dev, 11:847–862. 1997.
162.
LandSC, WilsonSM. Redox regulation of lung development and perinatal lung epithelial function. Antioxid Redox Signal, 7:92–107. 2005.
LatresE, MalumbresM, SotilloR, MartinJ, OrtegaS, Martin-CaballeroJ, FloresJM, Cordon-CardoC, BarbacidM. Limited overlapping roles of P15(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis. EMBO J, 19:3496–3506. 2000.
165.
LaurentA, NiccoC, ChereauC, GoulvestreC, AlexandreJ, AlvesA, LevyE, GoldwasserF, PanisY, SoubraneO, WeillB, BatteuxF. Controlling tumor growth by modulating endogenous production of reactive oxygen species. Cancer Res, 65:948–956. 2005.
166.
LebovitzRM, ZhangH, VogelH, CartwrightJJr, DionneL, LuN, HuangS, MatzukMM. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc Natl Acad Sci U S A, 93:9782–9787. 1996.
167.
LevonenAL, PatelRP, BrookesP, GoYM, JoH, ParthasarathyS, AndersonPG, Darley-UsmarVM. Mechanisms of cell signaling by nitric oxide and peroxynitrite: from mitochondria to MAP kinases. Antioxid Redox Signal, 3:215–29. 2001.
168.
LiJJ, OberleyLW, St ClairDK, RidnourLA, OberleyTD. Phenotypic changes induced in human breast cancer cells by overexpression of manganese-containing super-oxide dismutase. Oncogene, 10:1989–2000. 1995.
169.
LiJM, BrooksG. Cell cycle regulatory molecules (cyclins, cyclin-dependent kinases and cyclin-dependent kinase inhibitors) and the cardiovascular system; potential targets for therapy?Eur Heart J, 20:406–420. 1999.
170.
LiJM, ShahAM. ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy. J Am Soc Nephrol, 14:S221–S226. 2003.
LieberCS. Relationships between nutrition, alcohol use, and liver disease. Alcohol Res Health, 27:220–231. 2003.
173.
LindnerV, ReidyMA. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci U S A, 88:3739–3743. 1991.
174.
LiuJQ, ZelkoIN, ErbynnEM, ShamJS, FolzRJ. Hypoxic pulmonary hypertension: role of superoxide and NADPH oxidase (gp91phox)Am J Physiol Lung Cell Mol Physiol, 290:L2–L10. 2006.
175.
LiuM, WikonkalNM, BrashDE. Induction of cyclin-dependent kinase inhibitors and G(1) prolongation by the chemopreventive agent N-acetylcysteine. Carcinogenesis, 20:1869–1872. 1999.
176.
LiuY, CigolaE, ChengW, KajsturaJ, OlivettiG, HintzeTH, AnversaP. Myocyte nuclear mitotic division and programmed myocyte cell death characterize the cardiac myopathy induced by rapid ventricular pacing in dogs. Lab Invest, 73:771–787. 1995.
177.
LoflinJ, LopezN, WhangerPD, KioussiC. Selenoprotein W during development and oxidative stress. J Inorg Biochem, 100:1679–1684. 2006.
178.
LuoS, BenathanM, RaffoulW, PanizzonRG, EgloffDV. Abnormal balance between proliferation and apoptotic cell death in fibroblasts derived from keloid lesions. Plast Reconstr Surg, 107:87–96. 2001.
179.
LyleAN, GriendlingKK. Modulation of vascular smooth muscle signaling by reactive oxygen species. Physiology (Bethesda), 21:269–280. 2006.
MahadevK, ZilberingA, ZhuL, GoldsteinBJ. Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1b in vivo and enhances the early insulin action cascade. J Biol Chem, 276:21938–21942. 2001.
183.
MajeskyMW, LindnerV, TwardzikDR, SchwartzSM, ReidyMA. Production of transforming growth factor beta 1 during repair of arterial injury. J Clin Invest, 88:904–910. 1991.
184.
MalumbresM, SotilloR, SantamariaD, GalanJ, CerezoA, OrtegaS, DubusP, BarbacidM. Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6. Cell, 118:493–504. 2004.
185.
MaresJ, WelshM. Expression of certain antiproliferative and growth-related genes in isolated mouse pancreatic islets: analysis by polymerase chain reaction. Diabetes Metab, 19:315–320. 1993.
186.
MarshallHE, StamlerJS. Exhaled nitric oxide (NO), NO synthase activity, and regulation of nuclear factor (NF)-kappaB. Am J Respir Cell Mol Biol, 21:296–297. 1999.
187.
MartinM, LefaixJ, DelanianS. TGF-beta1 and radiation fibrosis: a master switch and a specific therapeutic target?Int J Radiat Oncol Biol Phys, 47:277–290. 2000.
188.
Martinez MunozC, PostJA, VerkleijAJ, VerripsCT, BoonstraJ. The effect of hydrogen peroxide on the cyclin D expression in fibroblasts. Cell Mol Life Sci, 58:990–996. 2001.
189.
MasseyV, StricklandS, MayhewSG, HowellLG, EngelPC, MatthewsRG, SchumanM, SullivanPA. The production of superoxide anion radicals in the reaction of reduced flavins and flavoproteins with molecular oxygen. Biochem Biophys Res Commun, 36:891–897. 1969.
190.
MatesJM, Sanchez-JimenezFM. Role of reactive oxygen species in apoptosis: implications for cancer therapy. Int J Biochem Cell Biol, 32:157–170. 2000.
191.
MatsuiM, OshimaM, OshimaH, TakakuK, MaruyamaT, YodoiJ, TaketoMM. Early embryonic lethality caused by targeted disruption of the mouse thioredoxin gene. Dev Biol, 178:179–185. 1996.
192.
MatsuokaY, PiccianoM, La FrancoisJ, DuffK. Fibrillar beta-amyloid evokes oxidative damage in a transgenic mouse model of Alzheimer's disease. Neuroscience, 104:609–613. 2001.
193.
MattsonMP, CamandolaS. NF-kappaB in neuronal plasticity and neurodegenerative disorders. J Clin Invest, 107:247–254. 2001.
194.
MatzukMM, DionneL, GuoQ, KumarTR, LebovitzRM. Ovarian function in superoxide dismutase 1 and 2 knockout mice. Endocrinology, 139:4008–4011. 1998.
195.
MaurizioP, NovoE. Nrf1 gene expression in the liver: a single gene linking oxidative stress to NAFLD, NASH and hepatic tumours. J Hepatol, 43:1096–1097. 2005.
196.
McCordJM, FridovichI. Superoxide dismutase: an enzymic function for erythrocuprein (hemocuprein)J Biol Chem, 244:6049–6055. 1969.
197.
McSheaA, HarrisPL, WebsterKR, WahlAF, SmithMA. Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. Am J Pathol, 150:1933–1939. 1997.
198.
MedemaRH, KopsGJ, BosJL, BurgeringBM. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature, 404:782–787. 2000.
199.
MenonSG, ColemanMC, WalshSA, SpitzDR, GoswamiPC. Differential susceptibility of nonmalignant human breast epithelial cells and breast cancer cells to thiol antioxidant-induced G(1)-delay. Antioxid Redox Signal, 7:711–718. 2005.
200.
MenonSG, GoswamiPC. A redox cycle within the cell cycle: ring in the old with the new. Oncogene, 26:1101–1109. 2007.
201.
MenonSG, SarsourEH, KalenAL, VenkataramanS, HitchlerMJ, DomannFE, OberleyLW, GoswamiPC. Superoxide signaling mediates N-acetyl-L-cysteine-induced G1 arrest: regulatory role of cyclin D1 and manganese superoxide dismutase. Cancer Res, 67:6392–6399. 2007.
202.
MenonSG, SarsourEH, SpitzDR, HigashikuboR, SturmM, ZhangH, GoswamiPC. Redox regulation of the G1 to S phase transition in the mouse embryo fibroblast cell cycle. Cancer Res, 63:2109–2117. 2003.
203.
MinaminoT, MitsialisSA, KourembanasS. Hypoxia extends the life span of vascular smooth muscle cells through telomerase activation. Mol Cell Biol, 21:3336–3342. 2001.
204.
MoertelCG, FlemingTR, CreaganET, RubinJ, O'ConnellMJ, AmesMM. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy: a randomized double-blind comparison. N Engl J Med, 312:137–141. 1985.
205.
MonteiroHP, IvaschenkoY, FischerR, SternA. Inhibition of protein tyrosine phosphatase activity by diamide is reversed by epidermal growth factor in fibroblasts. FEBS Lett, 295:146–148. 1991.
206.
MoustakasA, SouchelnytskyiS, HeldinCH. Smad regulation in TGF-beta signal transduction. J Cell Sci, 114:4359–4369. 2001.
207.
MudgeBP, HarrisC, GilmontRR, AdamsonBS, ReesRS. Role of glutathione redox dysfunction in diabetic wounds. Wound Repair Regen, 10:52–58. 2002.
208.
MurphyM. Delayed early embryonic lethality following disruption of the murine cyclin A2 gene. Nat Genet, 23:481. 1999.
209.
MurphyM, StinnakreMG, Senamaud-BeaufortC, WinstonNJ, SweeneyC, KubelkaM, CarringtonM, BrechotC, Sobczak-ThepotJ. Delayed early embryonic lethality following disruption of the murine cyclin A2 gene. Nat Genet, 15:83–86. 1997.
210.
NabelEG, YangZ, LiptayS, SanH, GordonD, HaudenschildCC, NabelGJ. Recombinant platelet-derived growth factor B gene expression in porcine arteries induce intimal hyperplasia in vivo. J Clin Invest, 91:1822–1829. 1993.
211.
NagyZ, EsiriMM, CatoAM, SmithAD. Cell cycle markers in the hippocampus in Alzheimer's disease. Acta Neuropathol, 94:6–15. 1997.
212.
NagyZ, EsiriMM, SmithAD. Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions. Acta Neuropathol, 93:294–300. 1997.
213.
NapoliC, LermanLO, de NigrisF, SicaV. c-Myc oncoprotein: a dual pathogenic role in neoplasia and cardiovascular diseases?Neoplasia, 4:185–190. 2002.
214.
NevinsJR. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science, 258:424–429. 1992.
215.
NguyenMD, BoudreauM, KrizJ, Couillard-DespresS, KaplanDR, JulienJP. Cell cycle regulators in the neuronal death pathway of amyotrophic lateral sclerosis caused by mutant superoxide dismutase 1. J Neurosci, 23:2131–2140. 2003.
216.
NishikawaT, EdelsteinD, DuXL, YamagishiS, MatsumuraT, KanedaY, YorekMA, BeebeD, OatesPJ, HammesHP, GiardinoI, BrownleeM. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature, 404:787–790. 2000.
217.
NishioE, WatanabeY. The involvement of reactive oxygen species and arachidonic acid in alpha 1-adrenoceptor-induced smooth muscle cell proliferation and migration. Br J Pharmacol, 121:665–670. 1997.
218.
NishiyamaA, MasutaniH, NakamuraH, NishinakaY, YodoiJ. Redox regulation by thioredoxin and thioredoxin-binding proteins. IUBMB Life, 52:29–33. 2001.
219.
NovoE, MarraF, ZamaraE, Valfre di BonzoL, CaligiuriA, CannitoS, AntonaciC, ColombattoS, PinzaniM, ParolaM. Dose dependent and divergent effects of superoxide anion on cell death, proliferation, and migration of activated human hepatic stellate cells. Gut, 55:90–97. 2006.
220.
NozatoT, ItoH, TamamoriM, AdachiS, AbeS, MarumoF, HiroeM. G1 cyclins are involved in the mechanism of cardiac myocyte hypertrophy induced by angiotensin II. Jpn Circ J, 64:595–601. 2000.
221.
NunomuraA, MoreiraPI, LeeHG, ZhuX, CastellaniRJ, SmithMA, PerryG. Neuronal death and survival under oxidative stress in Alzheimer and Parkinson diseases. CNS Neurol Disord Drug Targets, 6:411–423. 2007.
222.
NunomuraA, PerryG, AlievG, HiraiK, TakedaA, BalrajEK, JonesPK, GhanbariH, WatayaT, ShimohamaS, ChibaS, AtwoodCS, PetersenRB, SmithMA. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol, 60:759–767. 2001.
223.
OberleyLW. Anticancer therapy by overexpression of superoxide dismutase. Antioxid Redox Signal, 3:461–472. 2001.
224.
OberleyLW, BuettnerGR. Role of superoxide dismutase in cancer: a review. Cancer Res, 39:1141–1149. 1979.
225.
OberleyTD, OberleyLW, SlatteryAF, LauchnerLJ, ElwellJH. Immunohistochemical localization of antioxidant enzymes in adult Syrian hamster tissues and during kidney development. Am J Pathol, 137:199–214. 1990.
226.
OjhaN, RoyS, HeG, BiswasS, VelayuthamM, KhannaS, KuppusamyP, ZweierJL, SenCK. Assessment of wound-site redox environment and the significance of Rac2 in cutaneous healing. Free Radic Biol Med, 44:682–691. 2008.
OlumiAF, GrossfeldGD, HaywardSW, CarrollPR, TlstyTD, CunhaGR. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res, 59:5002–5011. 1999.
229.
OmennGS, GoodmanG, ThornquistM, GrizzleJ, RosenstockL, BarnhartS, BalmesJ, CherniackMG, CullenMR, GlassA, KeoghJ, MeyskensFJr, ValanisB, WilliamsJJr. The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers. Cancer Res, 54:2038s–2043s. 1994.
230.
OrrWC, SohalRS. Extension of life-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster. Science, 263:1128–1130. 1994.
231.
OrtegaS, PrietoI, OdajimaJ, MartinA, DubusP, SotilloR, BarberoJL, MalumbresM, BarbacidM. Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice. Nat Genet, 35:25–31. 2003.
232.
PadayattySJ, LevineM. Reevaluation of ascorbate in cancer treatment: emerging evidence, open minds and serendipity. J Am Coll Nutr, 19:423–425. 2000.
PearsonP, LewisSA, BrittonJ, YoungIS, FogartyA. The pro-oxidant activity of high-dose vitamin E supplements in vivo. BioDrugs, 20:271–273. 2006.
239.
PenningtonJD, JacobsKM, SunL, Bar-SelaG, MishraM, GiusD. Thioredoxin and thioredoxin reductase as redox-sensitive molecular targets for cancer therapy. Curr Pharm Des, 13:3368–3377. 2007.
240.
PenningtonJD, WangTJ, NguyenP, SunL, BishtK, SmartD, GiusD. Redox-sensitive signaling factors as a novel molecular targets for cancer therapy. Drug Resist Update, 8:322–330. 2005.
241.
PratMI, AdamoAM, GonzalezSA, AffranchinoJL, IkedaM, MatsubaraE, ShojiM, SmithMA, CastanoEM, MorelliL. Presenilin 1 overexpressions in Chinese hamster ovary (CHO) cells decreases the phosphorylation of retinoblastoma protein: relevance for neurodegeneration. Neurosci Lett, 326:9–12. 2002.
242.
QiuP, ZhaoTY, LiXJ, LiuSY, LiXY. [Damage mechanism of intermittent exposure to high concentrations of glucose to beta cell lines (HIT-T15 cell)]Sichuan Da Xue Xue Bao Yi Xue Ban, 39:69–71, 93. 2008.
RadunovicA, LeighPN. ALSODatabase: database of SOD1 (and other) gene mutations in ALS on the Internet: European FALS Group and ALSOD Consortium. Amyotroph Lateral Scler Other Motor Neuron Disord, 1:45–49. 1999.
245.
RahaS, RobinsonBH. Mitochondria, oxygen free radicals, and apoptosis. Am J Med Genet, 106:62–70. 2001.
246.
RahmanI, YangSR, BiswasSK. Current concepts of redox signaling in the lungs. Antioxid Redox Signal, 8:681–689. 2006.
RaneSG, DubusP, MettusRV, GalbreathEJ, BodenG, ReddyEP, BarbacidM. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia. Nat Genet, 22:44–52. 1999.
250.
RaneSG, ReddyEP. Cell cycle control of pancreatic beta cell proliferation. Front Biosci, 5:D1–19. 2000.
251.
RanganathanS, BowserR. Alterations in G(1) to S phase cell-cycle regulators during amyotrophic lateral sclerosis. Am J Pathol, 162:823–835. 2003.
252.
RanjanP, AnathyV, BurchPM, WeiratherK, LambethJD, HeintzNH. Redox-dependent expression of cyclin D1 and cell proliferation by Nox1 in mouse lung epithelial cells. Antioxid Redox Signal, 8:1447–1459. 2006.
253.
RaoGN, BerkBC. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ Res, 70:593–599. 1992.
254.
RaoGN, LassegueB, GriendlingKK, AlexanderRW. Hydrogen peroxide stimulates transcription of c-jun in vascular smooth muscle cells: role of arachidonic acid. Oncogene, 8:2759–2764. 1993.
255.
RapkineL. Su les processus chimiques au cours de la division cellulaire. Ann Physiol Physiochem Biol, 7:382–418. 1931.
256.
RasikAM, ShuklaA. Antioxidant status in delayed healing type of wounds. Int J Exp Pathol, 81:257–263. 2000.
257.
RavitzMJ, YanS, DolceC, KinniburghAJ, WennerCE. Differential regulation of p27 and cyclin D1 by TGF-beta and EGF in C3H 10T1/2 mouse fibroblasts. J Cell Physiol, 168:510–520. 1996.
258.
ReissK, ChengW, GiordanoA, De LucaA, LiB, KajsturaJ, AnversaP. Myocardial infarction is coupled with the activation of cyclins and cyclin-dependent kinases in myocytes. Exp Cell Res, 225:44–54. 1996.
259.
RheeSG, BaeYS, LeeSR, KwonJ. Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation. Sci STKE, 2000:PE1. 2000.
260.
RheeSG, ChangTS, BaeYS, LeeSR, KangSW. Cellular regulation by hydrogen peroxide. J Am Soc Nephrol, 14:S211–SW215. 2003.
261.
RheeSG, KangSW, ChangTS, JeongW, KimK. Peroxiredoxin, a novel family of peroxidases. IUBMB Life, 52:35–41. 2001.
262.
RheeSG, KangSW, NettoLE, SeoMS, StadtmanER. A family of novel peroxidases, peroxiredoxins. Biofactors, 10:207–209. 1999.
RodningenOK, Borresen-DaleAL, AlsnerJ, HastieT, OvergaardJ. Radiation-induced gene expression in human subcutaneous fibroblasts is predictive of radiation-induced fibrosis. Radiother Oncol, 86:314–320. 2008.
265.
RomanskaHM, PolakJM, ColemanRA, JamesRS, HarmerDW, AllenJC, BishopAE. iNOS gene upregulation is associated with the early proliferative response of human lung fibroblasts to cytokine stimulation. J Pathol, 197:372–379. 2002.
266.
RosenkranzS. TGF-beta1 and angiotensin networking in cardiac remodeling. Cardiovasc Res, 63:423–432. 2004.
267.
RossR. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature, 362:801–809. 1993.
268.
RotterJI, VadheimCM, RimoinDL. RifkinH, PorterD. Genetics of diabetes mellitus. Diabetes mellitus: theory and practice, 4th. Amsterdam: Elsevier, 1990; 378–413.
RoyS, KhannaS, NalluK, HuntTK, SenCK. Dermal wound healing is subject to redox control. Mol Ther, 13:211–220. 2006.
271.
RubinH, ChowM, YaoA. Cellular aging, destabilization, and cancer. Proc Natl Acad Sci U S A, 93:1825–1830. 1996.
272.
SadoshimaJ, AokiH, IzumoS. Angiotensin II and serum differentially regulate expression of cyclins, activity of cyclin-dependent kinases, and phosphorylation of retinoblastoma gene product in neonatal cardiac myocytes. Circ Res, 80:228–241. 1997.
273.
SaeedM, YangY, DengHX, HungWY, SiddiqueN, DellefaveL, GelleraC, AndersenPM, SiddiqueT. Age and founder effect of SOD1 A4V mutation causing ALS. Neurology, 72:1634–1639. 2009.
SalonenJT, NyyssonenK, TuomainenTP, MaenpaaPH, KorpelaH, KaplanGA, LynchJ, HelmrichSP, SalonenR. Increased risk of non-insulin dependent diabetes mellitus at low plasma vitamin E concentrations: a four year follow up study in men. Br Med J, 311:1124–1127. 1995.
276.
SarsourEH, AgarwalM, PanditaTK, OberleyLW, GoswamiPC. Manganese superoxide dismutase protects the proliferative capacity of confluent normal human fibroblasts. J Biol Chem, 280:18033–18041. 2005.
277.
SarsourEH, VenkataramanS, KalenAL, OberleyLW, GoswamiPC. Manganese superoxide dismutase activity regulates transitions between quiescent and proliferative growth. Aging Cell, 7:405–417. 2008.
278.
SauerH, WartenbergM, HeschelerJ. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell Physiol Biochem, 11:173–186. 2001.
SayreLM, PerryG, HarrisPL, LiuY, SchubertKA, SmithMA. In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals. J Neurochem, 74:270–279. 2000.
SchaferFQ, BuettnerGR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med, 30:1191–1212. 2001.
283.
SchmidtM, Fernandez de MattosS, van der HorstA, KlompmakerR, KopsGJ, LamEW, BurgeringBM, MedemaRH. Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D. Mol Cell Biol, 22:7842–7852. 2002.
SchrinerSE, LinfordNJ, MartinGM, TreutingP, OgburnCE, EmondM, CoskunPE, LadigesW, WolfN, Van RemmenH, WallaceDC, RabinovitchPS. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science, 308:1909–1911. 2005.
286.
SchwartzSM, deBloisD, O'BrienER. The intima: soil for atherosclerosis and restenosis. Circ Res, 77:445–465. 1995.
287.
SebastianB, KakizukaA, HunterT. Cdc25M2 activation of cyclin-dependent kinases by dephosphorylation of threonine-14 and tyrosine-15. Proc Natl Acad Sci U S A, 90:3521–3524. 1993.
288.
SekharamM, TrottiA, CunnickJM, WuJ. Suppression of fibroblast cell cycle progression in G1 phase by N-acetylcysteine. Toxicol Appl Pharmacol, 149:210–216. 1998.
289.
SemseiI. On the nature of aging. Mech Ageing Dev, 117:93–108. 2000.
SenelO, CetinkaleO, OzbayG, AhciogluF, BulanR. Oxygen free radicals impair wound healing in ischemic rat skin. Ann Plast Surg, 39:516–523. 1997.
292.
SerafiniM, VillanoD, SperaG, PellegriniN. Redox molecules and cancer prevention: the importance of understanding the role of the antioxidant network. Nutr Cancer, 56:232–240. 2006.
293.
SerraV, von ZglinickiT, LorenzM, SaretzkiG. Extracellular superoxide dismutase is a major antioxidant in human fibroblasts and slows telomere shortening. J Biol Chem, 278:6824–6830. 2003.
294.
SerranoM, BlascoMA. Putting the stress on senescence. Curr Opin Cell Biol, 13:748–753. 2001.
295.
SerranoM, LeeH, ChinL, Cordon-CardoC, BeachD, DePinhoRA. Role of the INK4a locus in tumor suppression and cell mortality. Cell, 85:27–37. 1996.
296.
ShackelfordRE, KaufmannWK, PaulesRS. Cell cycle control, checkpoint mechanisms, and genotoxic stress. Environ Health Perspect, 107,suppl 1:5–24. 1999.
297.
ShafrirE. Development and consequences of insulin resistance: lessons from animals with hyperinsulinaemia. Diabetes Metab, 22:122–131. 1996.
298.
SharmaGG, GuptaA, WangH, ScherthanH, DharS, GandhiV, IliakisG, ShayJW, YoungCS, PanditaTK. hTERT associates with human telomeres and enhances genomic stability and DNA repair. Oncogene, 22:131–146. 2003.
299.
SherrCJ. Mammalian G1 cyclins and cell cycle progression. Proc Assoc Am Physicians, 107:181–186. 1995.
300.
SherrCJ, RobertsJM. Living with or without cyclins and cyclin-dependent kinases. Genes Dev, 18:2699–2711. 2004.
301.
ShinHS, LeeHJ, NishidaM, LeeMS, TamuraR, YamashitaS, MatsuzawaY, LeeIK, KohGY. Betacellulin and amphiregulin induce upregulation of cyclin D1 and DNA synthesis activity through differential signaling pathways in vascular smooth muscle cells. Circ Res, 93:302–310. 2003.
302.
ShuklaA, RasikAM, PatnaikGK. Depletion of reduced glutathione, ascorbic acid, vitamin E and antioxidant defence enzymes in a healing cutaneous wound. Free Radic Res, 26:93–101. 1997.
303.
SicinskaE, AifantisI, Le CamL, SwatW, BorowskiC, YuQ, FerrandoAA, LevinSD, GengY, von BoehmerH, SicinskiP. Requirement for cyclin D3 in lymphocyte development and T cell leukemias. Cancer Cell, 4:451–461. 2003.
304.
SicinskiP, DonaherJL, GengY, ParkerSB, GardnerH, ParkMY, RobkerRL, RichardsJS, McGinnisLK, BiggersJD, EppigJJ, BronsonRT, ElledgeSJ, WeinbergRA. Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature, 384:470–474. 1996.
SimonHU, Haj-YehiaA, Levi-SchafferF. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis, 5:415–418. 2000.
307.
SinnaeveP, VarenneO, CollenD, JanssensS. Gene therapy in the cardiovascular system: an update. Cardiovasc Res, 44:498–506. 1999.
308.
SmithJR, Pereira-SmithOM. Replicative senescence: implications for in vivo aging and tumor suppression. Science, 273:63–67. 1996.
309.
SmithTW, LippaCF. Ki-67 immunoreactivity in Alzheimer's disease and other neurodegenerative disorders. J Neuropathol Exp Neurol, 54:297–303. 1995.
310.
St ClairDK, OberleyTD, MuseKE, St ClairWH. Expression of manganese superoxide dismutase promotes cellular differentiation. Free Radic Biol Med, 16:275–282. 1994.
311.
SteilingH, MunzB, WernerS, BrauchleM. Different types of ROS-scavenging enzymes are expressed during cutaneous wound repair. Exp Cell Res, 247:484–494. 1999.
312.
SteinhublSR. Why have antioxidants failed in clinical trials?Am J Cardiol, 101:14D–19D. 2008.
313.
StollLL, McCormickML, DenningGM, WeintraubNL. Antioxidant effects of statins. Timely Top Med Cardiovasc Dis, 9:E1. 2005.
314.
SullivanSG, ChiuDT, ErrasfaM, WangJM, QiJS, SternA. Effects of H2O2 on protein tyrosine phosphatase activity in HER14 cells. Free Radic Biol Med, 16:399–403. 1994.
315.
SundaresanM, YuZX, FerransVJ, IraniK, FinkelT. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science, 270:296–299. 1995.
316.
SwenneI. Effects of aging on the regenerative capacity of the pancreatic B-cell of the rat. Diabetes, 32:14–19. 1983.
317.
SylvesterAM, ChenD, KrasinskiK, AndresV. Role of c-fos and E2F in the induction of cyclin A transcription and vascular smooth muscle cell proliferation. J Clin Invest, 101:940–948. 1998.
318.
TeminHM. Stimulation by serum of multiplication of stationary chicken cells. J Cell Physiol, 78:161–170. 1971.
319.
ThannickalVJ, FanburgBL. Activation of an H2O2-generating NADH oxidase in human lung fibroblasts by transforming growth factor beta 1. J Biol Chem, 270:30334–30338. 1995.
320.
TonksNK. Redox redux: revisiting PTPs and the control of cell signaling. Cell, 121:667–670. 2005.
321.
TothovaZ, GillilDG. FoxO transcription factors and stem cell homeostasis: insights from the hematopoietic system. Cell Stem Cell, 1:140–152. 2007.
322.
TothovaZ, KolliparaR, HuntlyBJ, LeeBH, CastrillonDH, CullenDE, McDowellEP, Lazo-KallanianS, WilliamsIR, SearsC, ArmstrongSA, PassegueE, DePinhoRA, GillilDG. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell, 128:325–339. 2007.
323.
ToyoshimaH, HunterT. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell, 78:67–74. 1994.
324.
TraisterA, AbashidzeS, GoldV, PlachtaN, KarchovskyE, PatelK, WeilM. Evidence that nitric oxide regulates cell-cycle progression in the developing chick neuroepithelium. Dev Dyn, 225:271–276. 2002.
325.
TsanMF. Superoxide dismutase and pulmonary oxygen toxicity: lessons from transgenic and knockout mice [Review]Int J Mol Med, 7:13–19. 2001.
326.
TsanMF, WhiteJE, CaskaB, EpsteinCJ, LeeCY. Susceptibility of heterozygous MnSOD gene-knockout mice to oxygen toxicity. Am J Respir Cell Mol Biol, 19:114–120. 1998.
327.
TschenSI, DhawanS, GurloT, BhushanA. Age-dependent decline in beta cell proliferation restricts the capacity of beta cell regeneration in mice. Diabetes, 58:1312–1320. 2009.
328.
TuBP, KudlickiA, RowickaM, McKnightSL. Logic of the yeast metabolic cycle: temporal compartmentalization of cellular processes. Science, 310:1152–1158. 2005.
329.
UchidaT, NakamuraT, HashimotoN, MatsudaT, KotaniK, SakaueH, KidoY, HayashiY, NakayamaKI, WhiteMF, KasugaM. Deletion of Cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice. Nat Med, 11:175–182. 2005.
330.
ValkoM, LeibfritzD, MoncolJ, CroninMT, MazurM, TelserJ. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol, 39:44–84. 2007.
331.
Van RemmenH, IkenoY, HamiltonM, PahlavaniM, WolfN, ThorpeSR, AldersonNL, BaynesJW, EpsteinCJ, HuangTT, NelsonJ, StrongR, RichardsonA. Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiol Genomics, 16:29–37. 2003.
332.
Vande BergJS, RoseMA, PayneWG, Haywood-ReidPL, RobsonMC. Significance of cell cycle for wound stratification in clinical trials: analysis of a pressure ulcer clinical trial utilizing cyclin D/cdk4. Wound Repair Regen, 11:11–18. 2003.
333.
VincentI, JichaG, RosadoM, DicksonDW. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J Neurosci, 17:3588–3598. 1997.
334.
von WangenheimKH, PetersonHP. Control of cell proliferation by progress in differentiation: clues to mechanisms of aging, cancer causation and therapy. J Theoret Biol, 193:663–678. 1998.
335.
Vozenin-BrotonsMC, SivanV, GaultN, RenardC, GeffrotinC, DelanianS, LefaixJL, MartinM. Antifibrotic action of Cu/Zn SOD is mediated by TGF-beta1 repression and phenotypic reversion of myofibroblasts. Free Radic Biol Med, 30:30–42. 2001.
WaltersDM, ChoHY, KleebergerSR. Oxidative stress and antioxidants in the pathogenesis of pulmonary fibrosis: a potential role for Nrf2. Antioxid Redox Signal, 10:321–332. 2008.
338.
WangC, LiZ, LuY, DuR, KatiyarS, YangJ, FuM, LeaderJE, QuongA, NovikoffPM, PestellRG. Cyclin D1 repression of nuclear respiratory factor 1 integrates nuclear DNA synthesis and mitochondrial function. Proc Natl Acad Sci U S A, 103:11567–11572. 2006.
339.
WangF, NguyenM, QinFX, TongQ. SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction. Aging Cell, 6:505–514. 2007.
WartenbergM, DiedershagenH, HeschelerJ, SauerH. Growth stimulation versus induction of cell quiescence by hydrogen peroxide in prostate tumor spheroids is encoded by the duration of the Ca(2+) response. J Biol Chem, 274:27759–27767. 1999.
342.
WassmannS, LaufsU, BaumerAT, MullerK, KonkolC, SauerH, BohmM, NickenigG. Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase. Mol Pharmacol, 59:646–654. 2001.
343.
WassmannS, LaufsU, MullerK, KonkolC, AhlboryK, BaumerAT, LinzW, BohmM, NickenigG. Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler Thromb Vasc Biol, 22:300–305. 2002.
344.
WaypaGB, MarksJD, MackMM, BoribounC, MungaiPT, SchumackerPT. Mitochondrial reactive oxygen species trigger calcium increases during hypoxia in pulmonary arterial myocytes. Circ Res, 91:719–726. 2002.
345.
WeiGL, KrasinskiK, KearneyM, IsnerJM, WalshK, AndresV. Temporally and spatially coordinated expression of cell cycle regulatory factors after angioplasty. Circ Res, 80:418–426. 1997.
346.
WeydertC, RolingB, LiuJ, HinkhouseMM, RitchieJM, OberleyLW, CullenJJ. Suppression of the malignant phenotype in human pancreatic cancer cells by the overexpression of manganese superoxide dismutase. Mol Cancer Ther, 2:361–369. 2003.
347.
WeydertCJ, WaughTA, RitchieJM, IyerKS, SmithJL, LiL, SpitzDR, OberleyLW. Overexpression of manganese or copper-zinc superoxide dismutase inhibits breast cancer growth. Free Radic Biol Med, 41:226–237. 2006.
348.
WrightWE, ShayJW. Cellular senescence as a tumor-protection mechanism: the essential role of counting. Curr Opin Genet Dev, 11:98–103. 2001.
349.
WrightWE, ShayJW. Historical claims and current interpretations of replicative aging. Nat Biotechnol, 20:682–688. 2002.
350.
YamamotoK, VolklA, HashimotoT, FahimiHD. Catalase in guinea pig hepatocytes is localized in cytoplasm, nuclear matrix and peroxisomes. Eur J Cell Biol, 46:129–135. 1988.
351.
YamauchiA, BloomET. Control of cell cycle progression in human natural killer cells through redox regulation of expression and phosphorylation of retinoblastoma gene product protein. Blood, 89:4092–4099. 1997.
352.
YanY, FrisenJ, LeeMH, MassagueJ, BarbacidM. Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes Dev, 11:973–983. 1997.
353.
YantLJ, RanQ, RaoL, Van RemmenH, ShibataniT, BelterJG, MottaL, RichardsonA, ProllaTA. The selenoprotein GPX4 is essential for mouse development and protects from radiation and oxidative damage insults. Free Radic Biol Med, 34:496–502. 2003.
ZangarRC, DavydovDR, VermaS. Mechanisms that regulate production of reactive oxygen species by cytochrome P450. Toxicol Appl Pharmacol, 199:316–331. 2004.
356.
ZhangP, LiegeoisNJ, WongC, FinegoldM, HouH, ThompsonJC, SilvermanA, HarperJW, DePinhoRA, ElledgeSJ. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature, 387:151–158. 1997.
357.
ZhangY, ZhaoW, ZhangHJ, DomannFE, OberleyLW. Overexpression of copper zinc superoxide dismutase suppresses human glioma cell growth. Cancer Res, 62:1205–1212. 2002.
ZieskeJD. Expression of cyclin-dependent kinase inhibitors during corneal wound repair. Prog Retin Eye Res, 19:257–270. 2000.
365.
ZouMH, ShiC, CohenRA. Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J Clin Invest, 109:817–826. 2002.
366.
ZweierJL. Measurement of superoxide-derived free radicals in the reperfused heart: evidence for a free radical mechanism of reperfusion injury. J Biol Chem, 263:1353–1357. 1988.
